Sonoma Pharmaceuticals, Inc.
Market Cap
$2.09M
P/E Ratio
-0.62
EPS
$-1.95
Dividend Yield
0.00%
52-Week Range
$0.85 — $6.92
Volume
316.05K
Avg Volume
153.17K
Beta
1.76
Get alerted when SNOA hits your target price.
Free — enter your email to get started
P/E (TTM)
-0.62
Forward P/E
—
PEG Ratio
-0.19
P/S (TTM)
0.24
P/B (TTM)
1.20
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.86%
ROA (TTM)
-0.25%
ROIC
—
Gross Margin
0.38%
Operating Margin
-0.16%
Net Margin
—
Debt/Equity
0.19
Current Ratio
2.88
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.44%
EPS Growth (5Y)
+0.29%
Sales Growth (3Y)
+0.04%
Sales Growth (5Y)
-0.03%
EPS Est (This Year)
$-1.61
EPS Est (Next Year)
$-0.56
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.50
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
0
Outstanding Shares
1.74M
Float
1.71M
Free Float %
98.22%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
Exchange
NASDAQ
IPO Date
2007-01-25
Employees
10
CEO
Amy Trombly
Index Membership
—
Website
https://www.sonomapharma.com
Sonoma Pharmaceuticals, Inc. (SNOA) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $2.09M, a P/E ratio of -0.62, SNOA is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare SNOA against other stocks using dozens of fundamental and technical filters.
DHB.V
Delivra Health Brands Inc.
$0.15
+0.00%
$4.69M
HASH.V
Simply Solventless Concentrates
$0.04
+0.00%
$5.20M
SXTC
China SXT Pharmaceuticals, Inc.
$2.07
+0.49%
$1.60M
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$0.69
-32.84%
$740.65K
CHLL.L
Chill Brands Group PLC
$0.40
+0.00%
$2.09M
APUS
Apimeds Pharmaceuticals US, Inc
$1.88
+0.00%
$2.36M
Sonoma Pharmaceuticals, Inc. (SNOA) has a trailing twelve-month (TTM) P/E ratio of -0.62. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Sonoma Pharmaceuticals, Inc. (SNOA) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Sonoma Pharmaceuticals, Inc. (SNOA) has a market capitalization of $2.09 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.